comparemela.com

Latest Breaking News On - Gen pharma stock down - Page 1 : comparemela.com

UroGen Pharma (NASDAQ:URGN) Stock Rating Reaffirmed by HC Wainwright

UroGen Pharma (NASDAQ:URGN) Stock Rating Reaffirmed by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Meitav Investment House Ltd Decreases Stock Holdings in UroGen Pharma Ltd (NASDAQ:URGN)

Meitav Investment House Ltd. trimmed its holdings in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 13.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,456 shares of the company’s stock after selling 14,056 shares during the quarter. Meitav Investment House […]

UroGen Pharma Ltd (NASDAQ:URGN) Short Interest Up 23 6% in November

UroGen Pharma Ltd (NASDAQ:URGN) Short Interest Up 23 6% in November
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Oppenheimer Comments on UroGen Pharma Ltd s FY2027 Earnings (NASDAQ:URGN)

UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) – Equities researchers at Oppenheimer issued their FY2027 earnings estimates for shares of UroGen Pharma in a report issued on Tuesday, March 28th. Oppenheimer analyst L. Gershell forecasts that the company will post earnings per share of $7.24 for the year. The consensus estimate for UroGen Pharma’s current […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.